Royce & Associates’s Enovix ENVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-119,037
Closed -$1.19M 779
2025
Q3
$1.19M Buy
+119,037
New +$1.32M 0.01% 642
2024
Q1
Sell
-66,286
Closed -$726K 890
2023
Q4
$726K Sell
66,286
-57,143
-46% -$561K 0.01% 761
2023
Q3
$1.36M Buy
123,429
+25,143
+26% +$359K 0.01% 701
2023
Q2
$1.55M Hold
98,286
0.02% 694
2023
Q1
$1.28M Hold
98,286
0.01% 735
2022
Q4
$1.07M Sell
98,286
-11,428
-10% -$141K 0.01% 748
2022
Q3
$1.76M Buy
109,714
+18,285
+20% +$270K 0.02% 646
2022
Q2
$713K Hold
91,429
0.01% 800
2022
Q1
$1.14M Hold
91,429
0.01% 795
2021
Q4
$2.18M Sell
91,429
-51,428
-36% -$1.25M 0.02% 710
2021
Q3
$2.36M Hold
142,857
0.02% 721
2021
Q2
$2.87M Buy
142,857
+57,143
+67% +$775K 0.02% 703
2021
Q1
$998K Buy
+85,714
New +$1.13M 0.01% 852

Other funds holding ENVX

Royce & Associates's ENVX Position: Q4 2025 in Review

Royce & Associates sold out of Enovix (ENVX) in Q4 2025, closing a stake of 119,037 shares — an estimated $1.19M sold.

Royce & Associates first reported a position in ENVX in Q1 2021 and held it in 13 quarters. The position peaked at $2.87M in Q2 2021. 318 funds tracked by Wall St. Rank hold ENVX as of Q4 2025.

  • Royce & Associates reported no remaining Enovix position as of Q4 2025 after selling out during the quarter.
  • Royce & Associates sold 119,037 Enovix shares in Q4 2025, an estimated $1.19M.
  • Royce & Associates first reported a position in Enovix in Q1 2021 and held it in 13 quarters.
  • Royce & Associates's Enovix position peaked at $2.87M in Q2 2021.
  • 318 funds tracked by Wall St. Rank held Enovix as of Q4 2025.

Based on Royce & Associates's 13F filing for Q4 2025, filed 9 Feb 2026.